Additionally, we know from CD8+ T cell studies, that a central memory subset expressing the chemokine receptor CCR7 (CD197) and CD62L (L-Selectin) has been shown to be more effective at controlling tumor in vivo than an effector memory subset [28,29,30]. This evidence concerns the gene CD8A and neoplasm.